Edition:
India

OraSure Technologies Inc (OSUR.OQ)

OSUR.OQ on NASDAQ Stock Exchange Global Select Market

17.62USD
23 Feb 2018
Change (% chg)

$0.23 (+1.32%)
Prev Close
$17.39
Open
$17.52
Day's High
$17.74
Day's Low
$17.26
Volume
156,956
Avg. Vol
300,945
52-wk High
$23.00
52-wk Low
$10.79

Chart for

About

OraSure Technologies, Inc. (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types. The... (more)

Overall

Beta: 1.42
Market Cap(Mil.): $1,322.97
Shares Outstanding(Mil.): 59.46
Dividend: --
Yield (%): --

Financials

BRIEF-Orasure Technologies Says Board Approved Appointment Of Michael Celano As Chairman

* ORASURE TECHNOLOGIES SAYS ON FEB 20, BOARD APPROVED APPOINTMENT OF MICHAEL CELANO AS CHAIRMAN, EFFECTIVE APRIL 1, 2018 - SEC FILING Source text for Eikon: (http://bit.ly/2CcOGwb) Further company coverage:

23 Feb 2018

BRIEF-Orasure Q4 Revenue Rose 47 Percent To $52 Million

* ORASURE ANNOUNCES RECORD 2017 FOURTH QUARTER AND FULL-YEAR FINANCIAL RESULTS

08 Feb 2018

BRIEF-Orasure Technologies Announces Management Succession Plan

* ORASURE TECHNOLOGIES INC - BOARD OF DIRECTORS HAS APPOINTED STEPHEN S. TANG, AS CO'S NEW PRESIDENT AND CHIEF EXECUTIVE OFFICER, EFFECTIVE AS OF APRIL 1

04 Jan 2018

BRIEF-Orasure Technologies' unit enters into $143 million deal for supply of Oragene Dx devices‍​

* Says unit has entered into a $143 million deal for the supply of Oragene Dx devices to a consumer genomics customer - SEC filing‍​ Source text for Eikon: Further company coverage:

22 Nov 2017

BRIEF-OraSure Technologies reports Q3 earnings per share $0.09

* OraSure Technologies Inc announces 2017 third quarter financial results

02 Nov 2017

Earnings vs. Estimates